These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30885952)

  • 1. Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes.
    Patel P; Gupta P; Burns A; Suwaidan AA; Cole R; Lane D; Seidu S; Khunti K
    Diabetes Care; 2019 Jun; 42(6):1132-1135. PubMed ID: 30885952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.
    Jing S; Naliboff A; Kaufman MB; Choy M
    J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus.
    Denicolò S; Reinstadler V; Keller F; Thöni S; Eder S; Heerspink HJL; Rosivall L; Wiecek A; Mark PB; Perco P; Leierer J; Kronbichler A; Oberacher H; Mayer G
    Diabetologia; 2024 Jul; 67(7):1283-1294. PubMed ID: 38647650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals.
    Lawson AJ; Hameed MA; Brown R; Cappuccio FP; George S; Hinton T; Kapil V; Lenart J; Lobo MD; Martin U; Menon M; Nightingale A; Rylance PB; Webb DJ; Dasgupta I
    J Hypertens; 2020 Jun; 38(6):1165-1173. PubMed ID: 32371807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence.
    Gupta P; Patel P; Štrauch B; Lai FY; Akbarov A; Gulsin GS; Beech A; Marešová V; Topham PS; Stanley A; Thurston H; Smith PR; Horne R; Widimský J; Keavney B; Heagerty A; Samani NJ; Williams B; Tomaszewski M
    Hypertension; 2017 Nov; 70(5):1042-1048. PubMed ID: 28847892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis.
    Tomaszewski M; White C; Patel P; Masca N; Damani R; Hepworth J; Samani NJ; Gupta P; Madira W; Stanley A; Williams B
    Heart; 2014 Jun; 100(11):855-61. PubMed ID: 24694797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring adherence to antihypertensive medication using an objective test in older adults attending primary care: cross-sectional study.
    Sheppard JP; Albasri A; Gupta P; Patel P; Khunti K; Martin U; McManus RJ; Hobbs FDR
    J Hum Hypertens; 2022 Dec; 36(12):1106-1112. PubMed ID: 34876657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.
    Calip GS; Elmore JG; Boudreau DM
    Breast Cancer Res Treat; 2017 Jan; 161(1):161-172. PubMed ID: 27826756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A personalised intervention programme aimed at improving adherence to oral antidiabetic and/or antihypertensive medication in people with type 2 diabetes mellitus, the INTENSE study: study protocol for a randomised controlled trial.
    Langendoen-Gort M; Al-Jabr H; Hugtenburg JG; Rutters F; de Wit M; Bhattacharya D; Abu-Hanna A; Farmer A; Elders PJM
    Trials; 2022 Sep; 23(1):731. PubMed ID: 36056388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonadherence Labeling in Primary Care: Bias by Race and Insurance Type for Adults With Type 2 Diabetes.
    Beltrán S; Lett E; Cronholm PF
    Am J Prev Med; 2019 Nov; 57(5):652-658. PubMed ID: 31564598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine Concentration Does Not Affect Biochemical Testing for Non-adherence.
    Burns AD; Alghamadi R; Iqbal A; Davies T; Lane D; Patel P; Gupta P
    J Anal Toxicol; 2021 Mar; 45(3):e1-e5. PubMed ID: 33300570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: A retrospective study.
    Kulkarni S; Rao R; Goodman JDH; Connolly K; O'Shaughnessy KM
    Medicine (Baltimore); 2021 Apr; 100(14):e24654. PubMed ID: 33832064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database.
    Farmer AJ; Rodgers LR; Lonergan M; Shields B; Weedon MN; Donnelly L; Holman RR; Pearson ER; Hattersley AT
    Diabetes Care; 2016 Feb; 39(2):258-263. PubMed ID: 26681714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol screening scores and medication nonadherence.
    Bryson CL; Au DH; Sun H; Williams EC; Kivlahan DR; Bradley KA
    Ann Intern Med; 2008 Dec; 149(11):795-804. PubMed ID: 19047026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct assessment of adherence and drug interactions in patients with hypertensive crisis-A cross-sectional study in the Emergency Department.
    Wallbach M; Lach N; Stock J; Hiller H; Mavropoulou E; Chavanon ML; Neurath H; Blaschke S; Lowin E; Herrmann-Lingen C; Müller GA; Koziolek MJ
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):55-63. PubMed ID: 30515967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients.
    Hamdidouche I; Jullien V; Boutouyrie P; Billaud E; Azizi M; Laurent S
    J Hypertens; 2017 Sep; 35(9):1891-1898. PubMed ID: 28505066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database.
    Kirkman MS; Rowan-Martin MT; Levin R; Fonseca VA; Schmittdiel JA; Herman WH; Aubert RE
    Diabetes Care; 2015 Apr; 38(4):604-9. PubMed ID: 25573883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes.
    Pladevall M; Williams LK; Potts LA; Divine G; Xi H; Lafata JE
    Diabetes Care; 2004 Dec; 27(12):2800-5. PubMed ID: 15562188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT).
    Beernink JM; Oosterwijk MM; Khunti K; Gupta P; Patel P; van Boven JFM; Lambers Heerspink HJ; Bakker SJL; Navis G; Nijboer RM; Laverman GD
    Diabetes Care; 2021 Jun; 44(6):1419-1425. PubMed ID: 33893164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of adherence to treatment in patients with resistant hypertension using toxicological serum analysis. A subgroup evaluation of the RESIST-POL study.
    Florczak E; Tokarczyk B; Warchoł-Celińska E; Szwench-Pietrasz E; Prejbisz A; Gosk M; Kabat M; Narkiewicz K; Januszewicz A; Kała M
    Pol Arch Med Wewn; 2015; 125(1-2):65-72. PubMed ID: 25578261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.